CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
Jierui Liu, Yanqing Liu, Yansong Lin, Jun Liang
Endocrinol Metab. 2019;34(3):215-225.   Published online September 26, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.3.215

Excel Download

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
OncoTargets and Therapy. 2014;1291   Crossref logo
Link1

Evolving Approaches in Managing Radioactive Iodine-Refractory Differentiated Thyroid Cancer
Endocrine Practice. 2014;20(3):263-275   Crossref logo
Link1 Link2 Link3

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
Endocrinology and Metabolism. 2019;34(3):215   Crossref logo
Link1 Link2 Link3

Taking Stock of Therapeutic Progress in Metastatic Radioactive Iodine–Refractory Differentiated Thyroid Cancer: What's Next?
Thyroid. 2013;23(4):383-384   Crossref logo
Link1 Link2

Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer
Cancer Management and Research. 2016;67   Crossref logo
Link1

Postoperative Radioactive Iodine Ablation and Treatment of Differentiated Thyroid Cancer
Surgery of the Thyroid and Parathyroid Glands. 2021;447-451.e1   Crossref logo
Link1 Link2

A multicentre, randomised, double-blind, parallel-group, placebo-controlled trial of apatinib in local progressive or metastatic radioactive iodine-refractory differentiated thyroid cancer
Annals of Oncology. 2017;28:v157   Crossref logo
Link1 Link2 Link3

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
Chonnam Medical Journal. 2019;55(3):127   Crossref logo
Link1 Link2 Link3

A multicentre, randomised, double-blind, parallel-group, placebo-controlled trial of apatinib in local progressive or metastatic radioactive iodine-refractory differentiated thyroid cancer
Annals of Oncology. 2017;28:v157   Crossref logo
Link1 Link2 Link3

Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC)
Value in Health. 2016;19(7):A708   Crossref logo
Link1 Link2